A study by Hosking et al. (A-44) was designed to compare the effects of alendronate and risedronate on bone mineral density (BMD). One of the outcome measures was the percent increase in BMD at 12 months. Alendronate produced a significantly higher percent change (4.8 percent) in BMD than risedronate (2.8 percent) with a p value < :001.